The largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.
[email protected]  |  
JPND Neurodegenerative Disease Research

Search

Menu

  • About
  • Activities
  • Projects
  • PPI
  • CSA BrainHealth
  • Data Hubs
    • Research Database
    • Global Cohort Portal
    • Experimental Models for Parkinson’s Disease
  • EU Research Infrastructure Access
  • News & Media
  • Join Us
    • About
    • Activities
    • Projects
    • PPI
    • CSA BrainHealth
    • Data Hubs
      • Research Database
      • Global Cohort Portal
      • Experimental Models for Parkinson’s Disease
    • EU Research Infrastructure Access
    • News & Media
    • Join Us
6 – Presentation Slides
Home » Major Activities » JPND/JPcofuND Symposiums » JPND SYMPOSIUM 2024 » 6 – Presentation Slides
  • 2019 Research and Innovation Strategy
    • Interview with SAB Chair Professor Thomas Gasser
    • Stakeholder Consultation
    • Workshops & Questionnaire
      • Precision Medicine Workshop
      • Public Health Workshop
      • Questionnaire on Non-Human Primates
  • JPND/JPcofuND Symposiums
    • JPND SYMPOSIUM 2019
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • Biomarkers
          • ADAGE: Pietro CORTELLI
          • BIOMARKAPD: Bengt WINBLAD
        • Disease Modelling and Target Identification
        • Genetics and Environmental Risk Factors
          • RiMod-FTD: Peter HEUTINK
        • Genetics-causative factors
          • EADB: Jean-Charles LAMBERT
        • Genomics and Epigenetics
        • Healthcare, Prevention and Treatment
          • MEETINGDEM
          • MIND-AD: Miia KIVIPELTO
        • Protein Misfolding
          • NeuTargets: Chiara Zurzolo
        • Synaptics and Molecular Mechanisms
          • INCURE
      • 4 – Interviews with JPND Chair, SAB Chair and SAB Members
        • a – Philippe Amouyel, JPND Chair
        • b – Thomas Gasser, SAB Chair
        • c – Stefano Cappa, SAB Member
        • d – Myrra Vernooij-Dassen, SAB Member
        • d – Philip Scheltens, SAB Member
      • 5 – Presentation Slides
      • 6 – Interviews with Winners of the Young Scientist Poster Prize
        • Luca Kleineidam – EADB
        • Niamh M. C. Connolly – CeBioND
        • Vincent Baudouin – PrPCPDK1
    • JPND SYMPOSIUM 2022
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • Health and Social Care
        • Pathway Analysis
        • Personalised Medicine
      • 4 – Interviews with JPND chair and SAB chair
        • a – Philippe Amouyel, JPND Chair
        • b – Thomas Gasser, SAB Chair
      • 5 – Presentation Slides
      • 6 – Young Scientist Poster Prize Awards
    • JPND SYMPOSIUM 2024
      • 1 – Symposium Video
      • 2 – Photo Gallery
      • 3 – Scientific Sessions
        • LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS (2021)
        • NOVEL IMAGING AND BRAIN STIMULATION METHODS (2020)
        • PERSONALISED MEDICINE (2019)
      • 4 – Interviews with JPND chair and SAB members
      • 5 – Interview with PPI Advisory Board Members
      • 6 – Presentation Slides
      • 7 – Young Scientist Poster Prize Awards
  • 2012 Research Strategy
    • Delivery of the Research Strategy
    • Expert workshops
      • Basic Research
      • Clinical Research
      • Healthcare Research
      • Final Workshop
    • Stakeholder Consultations
      • Industry Meeting
      • Patient and Carer Meeting
      • Online Consultation
      • One-to-One consultations
    • Launch of the 2012 Research Strategy
  • JPco-fuND 2
  • Operating Plan
    • Implementation Plan, 2012-2014
  • Alignment Actions
    • Alignment of National Strategies
    • Alignment of National Activities
    • Longitudinal Cohorts
      • Call for Working Groups
        • Cohort Working Groups
        • Reports
        • FAQ + Webinar
          • FAQ
        • Interview with Philippe Amouyel
    • Assisted Living Technologies
    • Industry Partnership
    • Animal and Cell Models
    • Palliative Care
    • Patient + Public Involvement
      • PPI Stakeholder Advisory Board
    • Optimisation of biomarkers
  • JPco-fuND
  • Annual Calls for Proposals
    • 2025 RESEARCH CALL ON HEALTH AND SOCIAL CARE RESEARCH WITH A FOCUS ON THE MODERATE AND LATE STAGES OF NEURODEGENERATIVE DISEASES
      • Country-Specific Details
    • Call Statistics
    • Closed Calls
      • 2020 Research Call on “Novel Imaging and Brain Stimulation Methods and Technologies Related to Neurodegenerative Diseases”
        • Country-Specific Details
        • Novel Imaging and Brain Stimulation Methods and Technologies Projects
      • 2021 Expert Working Groups Call On “THE IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASE RESEARCH” 
        • Results of the 2021 JPND Working Groups Call: The Impact of Covid-19 on Neurodegenerative Disease Research
      • 2021 Research Call on “LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS TO NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • Linking Pre-Diagnosis Disturbances of Physiological Systems to Neurodegenerative Diseases Projects
      • 2022 EXPERT WORKING GROUPS CALL ON “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
        • RESULTS OF THE 2022 JPND EXPERT WORKING GROUPS CALL FOR “CONCEPTS FOR HEALTH AND SOCIAL CARE RESEARCH FOR NEURODEGENERATIVE DISEASES”
      • 2022 Research Call on “UNDERSTANDING THE MECHANISMS OF NON-PHARMACOLOGICAL INTERVENTIONS”
        • Country-Specific Details
        • Understanding the Mechanisms for Non-Pharmacological Interventions Projects
      • 2023 RESEARCH CALL ON “LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • Large Scale Analysis of OMICS Data for Drug-Target Finding in Neurodegenerative Diseases Projects
      • 2023 Working Groups Call on “Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice”
        • Results of the 2023 Working Groups Call: Use of Digital Technologies in Neurodegenerative Disease Research and Clinical Practice
      • 2024 RESEARCH CALL ON “MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES”
        • Country-Specific Details
        • MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE EARLY PHASE OF NEURODEGENERATIVE DISEASES
      • PRE-CALL ANNOUNCEMENT FOR JPND 2023 CALL: LARGE SCALE ANALYSIS OF OMICS DATA FOR DRUG-TARGET FINDING IN NEURODEGENERATIVE DISEASES
      • PRE-CALL ANNOUNCEMENT FOR JPND 2023 WORKING GROUPS CALL: USE OF DIGITAL TECHNOLOGIES IN NEURODEGENERATIVE DISEASE RESEARCH AND CLINICAL PRACTICE
      • 2019 Research Call on “Personalised Medicine”
        • Personalised Medicine Projects
        • Country-Specific Details
      • Health and Social Care 2018
        • Country-specific details
        • Health and social care projects
      • Pathways 2017
        • Country-specific details
        • Pathways projects
      • Brain Imaging Working Groups 2016
        • Brain Imaging Working Groups
        • FAQ
        • Final Reports
      • Risk Factors, Models and Cohorts 2015
        • JPND / JPco-fuND Symposium 2019
        • Call topics synopsis
          • Specific regulations
          • FAQ
            • General Framework
            • Building a consortium
            • Writing a Proposal
            • Evaluation and Decision
        • JPco-fuND Intermediate Symposium
        • JPco-fuND Projects
        • Monitoring Report
        • Survey of call applicants
      • Preventive Strategies 2013
        • Preventive Strategy Pilot Projects
        • National-level details
      • Cross-Disease Analysis 2013
        • Country-specific details 2013
        • Cross-Disease Analysis Projects
      • Healthcare Evaluation 2012
        • Healthcare Evaluation Projects
          • ActifCare
          • ALS-CarE
          • CLASP
          • MEETINGDEM
          • RHAPSODY
          • NEEDS in ALS
      • Risk Factors 2012
        • Risk Factor Projects
          • APGeM
          • COURAGE-PD
          • PERADES
          • RiMod-FTD
          • STRENGTH
      • Biomarkers Call 2011
        • National Contact Representatives
        • Biomarker Projects
          • BIOMARKAPD
          • CSFQUIC
          • DEMTEST
          • SOPHIA
  • Network of Centres of Excellence
    • Results of the Fourth CoEN Call
    • Results of Third CoEN Call
    • Participating Centres of Excellence
    • Results of First CoEN Call
    • Results of Second CoEN Call
  • Research Mapping
    • 2016 Report
    • Data Collected
    • 2011 Report
  • Monitoring and Evaluation
  • Linked Activities

JPND SYMPOSIUM 2024

Presentation slides
PERSONALISED MEDICINE (2019)
ADAIR PMG-AD GENFI-prox DIPPA-FTD SORLA-FIX MIDDEL PMI-AD GPA-PaCTS OligoFIT bPRIDE
NOVEL IMAGING AND BRAIN STIMULATION METHODS (2020)
DynaSti NIPARK NEURIPIDES PDWALK REMOPD NEUROPHAGE BioClotAD SCAIFILED BRAINSTORM DEBBIE ImageTDP43
LINKING PRE-DIAGNOSIS DISTURBANCES OF PHYSIOLOGICAL SYSTEMS (2021)
ProFFile ADIS SynaDeg IronSleep MIND FACE HBCI LeMeReND CONTROL-PD PreSSAD PremodiALS PD-PAM SOLID TACKL-PRED

VIEW ALL JPND NEWS & MEDIA

footer-logo

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases, in particular, Alzheimer’s.

Join Us

Twitter Feed

Tweets by @JPNDeurope

Contact Us

General enquiries: [email protected]

This initiative has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No. 643417, No. 681043 and No. 825664.

EU emblem

©2023 JPND Research | Privacy Policy | Cookie Policy |  Hosted By SmartHost | Site by Ten10